Page 4,609«..1020..4,6084,6094,6104,611..4,6204,630..»

BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit

Posted: Published on February 18th, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 9th Annual Stem Cell Summit in New York. Dr. West will speak in the session Disrupting the Pharma Model with Allogeneic Stem Cell Therapies on February 18, 2014, starting at 9:05 a.m. EST. Dr. West will discuss the potential comparative advantages of treating disease with BioTime's PureStem-based therapeutics compared to traditional small molecule pharmaceuticals and BioTime's product development strategy. The presentation will be made available on BioTime's website at http://www.biotimeinc.com. About BioTime, Inc. BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTimes focus is on pluripotent stem cell technology based on human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells. hES and iPS cells provide a means of manufacturing every cell type in the human body and therefore show considerable promise for the development of a number of … Continue reading →

Posted in Cell Medicine | Comments Off on BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit

Cody Johnson 2005 – Video

Posted: Published on February 18th, 2014

Cody Johnson 2005 This video starts soon after Cody's stem cell transplant. It stars Cody's girlfriend and family member Lori... By: Mickey Johnson … Continue reading →

Posted in Stem Cell Transplant | Comments Off on Cody Johnson 2005 – Video

Image anomalies cast shadow on acid-bath stem-cell study

Posted: Published on February 18th, 2014

12 hours ago by Bob Yirka Stress-treated lymphocytes expressed pluripotency marker Oct4. Right: STAP cells. Credit: Haruko Obokata (Phys.org) Japanese research center RIKEN has opened an investigation, Nature is reporting, related to reports of anomalies with images published in the same journal as part of a paper on a revolutionary approach to generating stem cells. The paper, titled "Stimulus-triggered fate conversion of somatic cells into pluripotency" described an acid-bath approach the team used to generate the type of stem cells that can grow into any body part. The approach was so much simpler than current methods that it created quite a stir in biology labs across the world. Soon after publication of the paper last month, however, comments began appearing on science blogs noting what appeared to be anomalies or inconsistencies with some of the images that were published along with the paper. Some suggested that one image had been spliced, others that parts of a placenta shown in one image may have been reused in another. As questions about the images used in the paper have grown, it appears that RIKEN, the institute where lead author and researcher Haruko Obokata works, has decided to look a little deeper to … Continue reading →

Posted in Stem Cell Transplant | Comments Off on Image anomalies cast shadow on acid-bath stem-cell study

Oriflame launches Bioclinic Active Defense Shield Day

Posted: Published on February 18th, 2014

Concerned about uneven complexion caused by hyper pigmentation? Now bid adieu to all your worries as Oriflames team of leading scientists, specialising in skin biology, have harnessed the most powerful active ingredients to deliverOriflame Bioclinic Active Defense Shield Day with SPF 45. Inspired by aesthetic medicine, the exclusive premium range captures the best of advanced science to promote even and brighter skin tone. As we get old, our skins natural skin renewal process becomes slower leading to hyper pigmentation and blemishes. Whilst we hide them with makeup concealers, the root cause of the problem remains intact. OriflamesBioclinic Active Defense Shield Day with SPF 45is a powerful anti-hyperpigmentation concentratethat works during the day to act upon the hyper pigmented areas to even skin tone and protect against further discoloration. Thepatented skin-lightening technologypromotes fading of pigmented skin cells and activates skin renewal to fast-track skin brightening. The Double- action fluid cream targets multiple forms of hyper pigmentation to provide a wholesome solution to ones skin troubles. Infused with active SPF 45 that provides high protection against sun-induced pigmentation, this multi-benefit lotion can also be used as a replacement for Day Cream or facial sunscreen. Its easy-to-use advanced pump tube makes it an … Continue reading →

Posted in Aesthetic Medicine | Comments Off on Oriflame launches Bioclinic Active Defense Shield Day

Dr. Samuel J. Beran – Top Plastic Surgeon in NYC & Westchester NY – Video

Posted: Published on February 18th, 2014

Dr. Samuel J. Beran - Top Plastic Surgeon in NYC Westchester NY http://www.drberan.com (914) 761-7070 - White Plains Mount Kisco: 440 MAMARONECK AVENUE SUITE 412 HARRISON, NY 10528 91 SMITH AVE., MOUNT KISCO, NY 10549 (... By: Dr Samuel J. Beran … Continue reading →

Posted in Aesthetic Surgery | Comments Off on Dr. Samuel J. Beran – Top Plastic Surgeon in NYC & Westchester NY – Video

Stemedica Issued U.S. Patent Method For Identifying Neuripotent Cells

Posted: Published on February 18th, 2014

San Diego, CA (PRWEB) February 18, 2014 Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced today that the company has been issued Patent No. US 8,642,286 B2 entitled, Methods for Identifying Neuripotent Cells by the United States Patent and Trademark Office. The Stemedica patent broadly covers a method for identifying the potency of a cell population, as it becomes neural cells, to engraft in the developing brain of a chick embryo. "This test contributes significantly to the screening of cells capable of engrafting and differentiating in vivo saving both time and valuable resources," said Alex Kharazi, MD, PhD, Chief Technology Officer at Stemedica. "It is a simple, cost-effective test of neural stem cell potency using a chicken embryonic brain, and is an important and effective step forward in the evaluation and testing of neuripotent cells." The chick embryo brain approximates an adult brain. The patented transplant method distinguishes neuripotent stem cells from those which fail to engraft and differentiate into neurons. The method is used for identifying chemical and genetic factors in the manufacture of efficacious neural stem cells. "In vitro propagated neural stem cells have shown great promise in treating … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Stemedica Issued U.S. Patent Method For Identifying Neuripotent Cells

Ultrasound Guided Stem Cell Treatment | Pectoralis Tendon Injection 1 – Video

Posted: Published on February 18th, 2014

Ultrasound Guided Stem Cell Treatment | Pectoralis Tendon Injection 1 Dr. Mercado performed an ultrasound guided stem cell injection into the pectoralis tendon. Learn more about our stem cell treatments at eternamdregenerativem... By: Eterna MD Regenerative Medicine … Continue reading →

Comments Off on Ultrasound Guided Stem Cell Treatment | Pectoralis Tendon Injection 1 – Video

Ultrasound Guided Stem Cell Treatment | Pectoralis Muscle Injection 1 – Video

Posted: Published on February 18th, 2014

Ultrasound Guided Stem Cell Treatment | Pectoralis Muscle Injection 1 Dr. Mercado performed an ultrasound guided stem cell injection into the pectoralis muscle. Learn more about our stem cell treatments at eternamdregenerativem... By: Eterna MD Regenerative Medicine … Continue reading →

Comments Off on Ultrasound Guided Stem Cell Treatment | Pectoralis Muscle Injection 1 – Video

Intl. Stem Cell readies for Parkinson's study

Posted: Published on February 18th, 2014

A proposed Parkinson's disease treatment from stem cells is on track for an application to be filed with federal regulators around the start of 2015, International Stem Cell Corp. said Tuesday. The Carlsbad-based company said the U.S. Food and Drug Administration had met with researchers for guidance on what steps need to be taken before filing an application. The meeting went about as expected, said Simon Craw, executive vice president. Ongoing animal studies must be completed, along with safety testing. FDA officials discussed details such as the number of animals to be tested and how the safety studies are to be conducted, Craw said. International Stem Cell's treatment consists of progenitor cells that mature into neural cells, including those making the neurotransmitter dopamine. These neurons are destroyed in the disease, causing progressive paralysis. The progenitor cells are to be implanted into the brains of Parkinson's patients, where they are expected to make dopamine and protect the remaining dopamine-making neurons. They are derived from unfertilized, or parthenogenetic, human egg cells, made to grow without fertilization. Human parthenogenetic neural stem cells in the process of differentiating into dopamine-producing neurons. / International Stem Cell Corp. Interim data from tests in primates are expected … Continue reading →

Comments Off on Intl. Stem Cell readies for Parkinson's study

Turning back the clock on aging muscles? – New study supports the possibility of localized rejuvenation

Posted: Published on February 18th, 2014

TORONTO, ON A study co-published in Nature Medicine this week by University of Toronto researcher Penney Gilbert has determined a stem cell-based method for restoring strength to damaged skeletal muscles of the elderly. Skeletal muscles are some of the most important muscles in the body, supporting functions such as sitting, standing, blinking and swallowing. In aging individuals, the function of these muscles significantly decreases. You lose fifteen percent of muscle mass every single year after the age of 75, a trend that is irreversible, cites Gilbert, Assistant Professor at the Institute of Biomaterials & Biomedical Engineering (IBBME) and the Donnelly Centre for Cellular & Biomolecular Research (CCBR). The study originates from Gilberts postdoctoral research at Stanford Universitys Baxter Laboratory for Stem Cell Biology. Through tracing the signaling pathways of the cells, the researchers including lead author, Professor Helen Blau, and postdoctoral researcher Ben Cosgrove determined that during aging, a subpopulation of stem cells begin to express a modification of a protein that inhibits their ability to grow and make new stem cells. But if we instead treated those cells outside the body with a drug that prevented that protein modification from occurring, in combination with culturing the cells on something … Continue reading →

Comments Off on Turning back the clock on aging muscles? – New study supports the possibility of localized rejuvenation

Page 4,609«..1020..4,6084,6094,6104,611..4,6204,630..»